HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.960
+0.120 (4.23%)
At close: Mar 28, 2025, 4:00 PM
2.800
-0.160 (-5.41%)
After-hours: Mar 28, 2025, 6:48 PM EDT
HeartSciences Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for HeartSciences stock have an average target of 13, with a low estimate of 12 and a high estimate of 14. The average target predicts an increase of 339.19% from the current stock price of 2.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HeartSciences stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +372.97% | Mar 18, 2025 |
Maxim Group | Maxim Group | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +305.41% | Dec 18, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +406.76% | Sep 23, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $330 | Strong Buy | Initiates | $330 | +11,048.65% | Jan 30, 2023 |
Maxim Group | Maxim Group | Strong Buy Maintains $800 → $300 | Strong Buy | Maintains | $800 → $300 | +10,035.14% | Dec 19, 2022 |
Financial Forecast
Revenue This Year
51.00K
from 18.60K
Increased by 174.19%
Revenue Next Year
2.14M
from 51.00K
Increased by 4,100.00%
EPS This Year
-9.65
from -18.74
EPS Next Year
-6.68
from -9.65
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 105,000 | 3.8M | 6.0M |
Avg | 51,000 | 2.1M | 5.8M |
Low | n/a | 588,000 | 5.6M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 464.5% | 7,311.8% | 179.4% |
Avg | 174.2% | 4,100.0% | 171.4% |
Low | - | 1,052.9% | 160.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -9.56 | -4.98 | -2.69 |
Avg | -9.65 | -6.68 | -2.61 |
Low | -9.62 | -8.18 | -2.51 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.